Get Permission Lakhani, Shah, Parikh, Ramchandani, and Prajapati: A histopathological spectrum of central nervous system lesion: Tertiary care hospital


Introduction

Human brain is considered to be the main centre of the body as it provides all the signals to organs to perform various functions.1 Space occupying lesions of CNS have variety in an aetiology like infections, neoplastic, inflammatory and any vascular malformation. There for, it is of great importance to establish an accurate diagnosis for timely neurosurgical intervention. 2

CNS can develop non-neoplastic space occupying lesions such as developmental malformation, cystic lesions and, infections. It can mimic tumour clinically and radiographically. Some of these lesions may require surgical resection. Recognition of any CNS lesions are necessary by clinically and imaging studies, because failing to differentiate between the nonneoplastic and neoplastic lesions may delay treatment in malignant tumours or result in unnecessary treatment in non-neoplastic lesions. 3

A variety of non -neoplastic CNS lesion with diverse etiopathogenesis occurs. With advance in neuro-imaging we can early recognise and diagnose it. 3

Most of non-neoplastic lesions are asymptomatic and they become symptomatic either by rupture, pressure or secondary inflammation. However, treatment and prognosis of these non-neoplastic lesions depends on type of the lesions; hence, histopathological examination of these lesions are necessary despite radiological findings.

Brain tumour constitute <2% of all neoplasms. It has bimodal age distribution with a peak at childhood and adult age group of 45-70 years. In children CNS tumours are 2nd most common tumours after leukemia. 4

Majority of patients with CNS neoplasms present clinically with headache, vomiting and/or seizures confusing with non-neoplastic lesions. So to differentiate between neoplastic and non-neoplastic lesions histopathological examination is required. Some of them with atypical presentation, requires advanced neuro-radiological procedures such as Computed Tomography scan (CT scan) and/or Magnetic Resonance Imaging scan (MRI scan) to localise site of CNS lesions. 5

The purpose of this study is to provide current overview of epidemiology of CNS lesions in our hospital setup and study the incidence of neoplastic lesions by using revised WHO classification 2016.

Materials and Methods

Retrospective study of total 69 CNS lesions was carried out in the Department of Pathology, Government Medical College and Hospital, Vadodara, Gujarat, India during period of January 2019 to April 2021.

Inclusion criteria

All CNS biopsies received in the department of pathology during the study period.

Exclusion criteria

Inadequate biopsies and poorly preserved tissue specimens were excluded from study.

Data analysis

Data was compiled in MS Excel, checked for its correctness and then analyzed.

Method

Biopsies of CNS lesions were preserved in 10%formalin, followed by fixation for 24 hours. Haematoxylin and Eosin stained sections of these CNS lesions were obtained by routine processing and paraffin embedding.

Clinical history of all cases was collected in a pretested proforma meeting the objectives of the study. Diagnosis is made in accordance with the WHO classification and diagnostic criteria for CNS neoplasms.

Result

Total 69 CNS lesion biopsies are examined during period of January 2019 to April 2021.

Out of total 69 cases, 54(78.26%) were neoplastic lesions and 15(21.74%) were non – neoplastic lesions.

Out of total 69 cases there were 38(55.07%) in female and 31(44.93%) in male. Out of total 38 biopsies from female patients, 30 were neoplastic and 08 were non-neoplastic. Out of the total 31 biopsies from male patients, 24 were neoplastic and 07 were non-neoplastic. (Figure 1)

Graph 1

Sex wise distribution of various CNS lesions.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/4a21ef17-e436-47fa-8e7a-14ea07eb5368image1.png

Out of total 69 biopsies, 14(20.29%) were from children (up to 18 years) and 55(79.71%) were from adult(more than 18 years). In children out of total 14 cases, 06 were neoplastic and 08 were nonneoplastic. In adult out of total 55 cases, 48 cases were neoplastic and 07 cases were non-neoplastic. (Figure 2)

Graph 2

Age wise distribution of various CNS lesions

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/4a21ef17-e436-47fa-8e7a-14ea07eb5368image2.png

Headache, convulsion and midline swelling were the most frequent presenting symptoms (headache being the most common) of patients and radiological examination showed SOLs (space occupying lesions) in most of the cases. (Table 1)

Table 1

Clinical presentations of CNS lesions.

Clinical features

Total no. of cases

Headache

19

Convulsion

12

Swelling

10

Difficulty in walking

08

Diminished vision

08

Vertigo

05

Generalised weakness

05

Difficulty in speaking

01

Hearing loss

01

Total

69

Out of 54 cases, 50(92.59%) were primary CNS tumours and 04(7.40%) were metastatic CNS lesions. Among primary CNS tumours, majority cases were Astrocytic tumours (n=15), followed by sellar region tumour (n=09), Schwannomas (n=07) and Meningiomas (n=07). (Table 2)

Table 2

Distribution and frequency of various neoplastic lesions.

Diagnosis according to    who classification

Total no. of cases

Diffuse astrocytic and oligodendroglial tumors

(14)

1). Diffuse astrocytoma

02

2). Anaplastic astrocytoma

02

3). Glioblastoma

08

4). Oligodendroglioma

02

Other astrocytic tumors

Pilocytic astrocytoma

03

Ependymal tumors

Myxopapillary ependymoma

01

Tumors of meninges

Meningioma

07

Tumors of cranial & paraspinal nerves

Schwannomas

07

Choroid plexus tumors

Choroid plexus papilloma

02

Embryonal tumour

Medulloblastoma

02

Neuronal and mixed neuronal-glial tumors

(04)

1). Ganglioglioma

02

2). Central neurocytoma

01

3). Diffuse leptomeningeal glioneuronal tumour

01

Mesenchymal non-meningothelial tumors

Hemangioblastoma

01

Tumors of sellar region

(09)

1). Craniopharyngioma

03

2). Pituitary adenoma

06

Metastatic tumors

04

Total

54

Out of total of 69 cases, 15 (21.74%) cases were non-neoplastic. Majority cases were showing cystic lesions (n=7, 46.67%) and developmental malformation (n=6,40.00%). (Table 3)

Table 3

Distribution and frequency of various non-neoplastic lesions.

Diagnosis according to who classification

Total no of cases

Developmental malformation

(06)

1)Lipomeningomyelocele

02

2)Meningomyelocele

03

3)Meningocele

01

Granulomatous lesions

01

Cystic lesions

(07)

1)Dermoid cyst

01

2)Epidermoid cyst

04

3)Arachnoid cyst

02

Hemangioma

01

Total

15

Discussion

The present study shows that 69 cases of CNS lesions share many of the features common with other published series (Table 4). Patients’ age ranged from 45 days to 72 years.

Table 4

Comparison of present study with different another CNS lesions study.

Present study

Jay Prakash et al 1

Ajay S T et al 6

Nidhi V S Et al 7

Himanshu J et al 5

Chang-Hyun L et al 8

T,S, Surawicz 9

Neuroepithelial tumours

27 (50%)

57 (50.89%)

127 (47.20%)

22 (43.13%)

33 (53.20%)

1102 (19.4%)

10635 (51.21%)

Meningeal tumours

07 (12.96%)

21 (18.75%)

59 (21.93%)

13 (25.49%)

12 (19.40%)

1775 (31.2%)

5257 (25.32%)

Tumours of cranial & paraspinal nerves

07 (12.96%)

19 (16.96%)

42 (15.60%)

11 (21.57%)

14 (22.60%)

634 (11.1%)

1357 (6.53%)

Pituitary Tumours

09 (16.67%)

05 (4.46%)

36 (13.38%)

04 (7.84%)

2 (3.20%)

901 (15.8%)

1853 (8.92%)

Metastatic tumours

04 (7.41%)

10 (8.92%)

3 (1.10%)

01 (1.96%)

1 (1.60%)

The most common presenting symptom in present series was headache which is supported by the findings of many other studies as well. 5, 7, 10. In non-neoplastic lesions, frequency of cystic lesions of CNS in the present study (n=7) compared well with other studies, 5, 10 which also revealed epidermoid cyst to be the predominant cystic lesion.

In the present study, tumours of the neuroepithelial origin (n=27,50%) represented maximum number of cases of intracranial neoplasms amongst all primary CNS tumours - in close agreement with observations made in various other studies by Ajay S T et al, Nidhi V S et al and T.S. Surawicz et al. 6, 7, 9

The studies by CH Lee et al (19.4%) and Aryal G (38.6%)., showed lower relative frequencies of neuroepithelial tumours 8, 11.

Astrocytoma constituted predominantly 22.22% of all CNS neoplasms which is comparable to 26.15%, 27.4% and 29.46% incidence reported by Nidhi S et al, Himanshu J et al and Jay P et al.7, 5, 1 The relative frequency of 12.9% of tumours of cranial and paraspinal nerves in the present study is in close agreement with other studies which reported 16.92% (Nidhi S et al.), 16.0% (Ajay S et al.) and 11.1% (CH Lee et al.).7, 8 However, choroid plexus papilloma constituted 3.7% in a similar way in studies done by Nidhi S et al but differed from other studies done by Kailash C J et al which was 1.69%.7, 12

The relative frequency of pituitary tumours in the present study was 16.67%, in close agreement with study done by CH Lee et at in Korea, which showed a relative frequency of 15.8%. 8 This difference in relative frequencies of different CNS lesions in the present study with other similar published studies may be attributed to differences in sample size, population and regional characteristics. Cystic lesions and developmental malformations were the predominant non-neoplastic lesions of present study.

Five most common primary site for malignant CNS tumour is lung, breast, skin (melanoma), kidney and gastrointestinal tract. 4 In present study also out of total 4 metastatic CNS tumours 2 were from Breast and 1 from skin had been reported.13

Figure 1

Metastatic CNS lesions, highly discohesive cells are seen in groups. Some of cells are also show signet ring appearance. Metastatic cells most likely from lobular carcinoma of breast. (H&E x 100)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/4a21ef17-e436-47fa-8e7a-14ea07eb5368image5.png

A variety of tumours occurs in CNS, but still accounts for less than 2% of all malignancies. But because of their location and mass effects, they generally have a poor prognosis. 8, 14

Figure 2

Craniopharyngioma, cords and lobules of well differentiated squamous cells and nodules of plump, anucleate squamous cells and wet keratin.(H&E x 100)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/4a21ef17-e436-47fa-8e7a-14ea07eb5368image6.png
Figure 3

Diffuse Leptomeningeal Glioneuronal Tumour, Infiltration of leptomeninges by scattered cells with round nuclei and clear cytoplasm without significant atypia and mitosis. (H&E x 100)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/4a21ef17-e436-47fa-8e7a-14ea07eb5368image7.png

Conclusion

In Central nervous system lesions Low grade tumours include low-grade astrocytoma, oligodendroglioma and mixed tumours, have been found over time to progress to high grade tumours. The time varies depending on the genetic and morphological makeup of the tumours. The same can be determined by proper examination of surgical specimen. Incidence and pattern of CNS neoplasm are subject to considerable geographical and racial variations. The availability of clinical information and neuro imaging techniques like CT scan and MRI imaging are of considerable importance for final histopathological diagnosis. The exact histopathological diagnosis of CNS lesions is essential to predict the prognosis and treatment because prognosis of high-grade tumour is grave and few of the patients may not even survive one year after diagnosis.

Conflict of Interest

None.

Source of Funding

None.

References

1 

J Prakash Histopathological study of tumours of Central Nervous SystemJ Med Sci Clin Res201861318347/10.18535/jmscr/v6i1.71

2 

Y Khonglah D Shangpliang J Mishra A Mustafa A Kakoti Pranjal Phukan; Histopathological spectrum of central nervous system lesions at a tertiary care centre in indiaClin Cancer Investig J2020951758110.4103/ccij.ccij_39_20

3 

AS Bhatt R Mhatre BN Nadeesh A Mahadevan TC Yasha V Santosh Nonneoplastic Cystic Lesions of the Central Nervous System-Histomorphological Spectrum: A Study of 538 CasesJ Neurosci Rural Pract201910349450110.1055/s-0039-1698033

4 

SN Kanthikar DB Nikumbh NV Dravid Histopathological overview of central nervous system tumour in North Maharashtra, India: a single center study Indian J Pathol Oncol201741804

5 

H Joshi S Awasthi S Dutta R Bhardwaj Histopathological spectrum of central nervous system lesionsTrop J Pathol Microbiol2019511844910.17511/jopm.2019.i11.02

6 

AS Thakur R Gahine V Kulkarni Vishal Kulkarni; A study on morphologic and histological pattern of the central nervous system tumoursInt J Res Med Sci201861238798210.18203/2320-6012.ijrms20184699

7 

TS Surawicz BJ Mccarthy V Kupelian PJ Jukich JM Bruner FG Faith Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994Neuro Oncol199011142510.1093/neuonc/1.1.14

8 

CH Lee KW Jung H Yoo S Park SH Lee Seung Hoon Lee; Epidemiology of primary Barin and Central Nervous System tumours in KoreaJ Korean Neurosurg Soc2010482145210.3340/jkns.2010.48.2.145

9 

NV Shihora HU Patel SM Patel PR Ramani BN Nandasana A study of histopathological spectrum of central nervous system lesions at a tertiary health care centre of south Gujarat, IndiaInt J Res Med Sci2020841451710.18203/2320-6012.ijrms20201341

10 

K Monga V K Gupta S Gupta K Marwah Clinicopathological study and epidemiological spectrum of brain tumours in RajasthanIndian J Basic App Med Res20155172834

11 

G Aryal Histopathological pattern of central nervous system tumour: A three-year retrospective studyJ Pathol Nepal20111122510.3126/jpn.v1i1.4445

12 

KC Jat SP Vyas NA Bihari K Mehra Kuldeep Mehra; Central Nervous system tumours: a histopathological studyInt J Res Med Sci201645153945/10.18203/2320-6012.ijrms20161225

13 

R Thambi S Kandamuthan S Sainulabdeen L Vilasiniamma TR Abraham PK Balakrishnan Histopathological Analysis of Brain Tumours- A Seven Year Study from a Tertiary Care Centre in South IndiaJ Clin Diagn Res2017116EC05810.7860/JCDR/2017/25623.9990

14 

V Madabhushi R I Venkata S Garikaparthi SV Kakarala SS Duttaluru Role of immunohistochemistry in diagnosis of brain tumours: A single institutional experienceJ NTR Univ Health Sci2015421031110.4103/2277-8632.154262



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 24-01-2023

Accepted : 10-03-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.jdpo.2023.005


Article Metrics






Article Access statistics

Viewed: 522

PDF Downloaded: 169



Medical Abbreviation List